Below are recent global medical technology market reports from MedMarket Diligence:
“Worldwide Drug-Eluting, Bare and Other Coronary Stents Market, 2008-2017.”. See details.
“Worldwide Market for Surgical Sealants, Glues, Wound Closure, 2009-2013.” See details.
“Ablation Technologies Worldwide Market, 2008-2017:Products, Technologies, Markets, Companies and Opportunities.” See details.
bookmark to
Approximately 70 million surgical and procedure-based wounds are created each year in surgeries worldwide that offer potential for adjunctive products for surgical closure and securement. Some 23 million of these wounds are created during surgical procedures in the United States. Although it is possible that healing of all these wounds would be improved through use [...]
The worldwide market for products used in securement (sutures, staple, hemostasis, tapes, surgical sealants, high-strength glues) is characterized by both well established markets (sutures, staples and tapes) and novel products (surgical sealants, hemostasis and high-strength glues).
The attractiveness of the surgical securement market is that there are some sizable segments that continue to demonstrate high annual [...]
There is potential for new sealant, hemostasis and closure treatments designed to facilitate surgical treatments of neurological disorders; most existing alternative treatments are pharmological therapies limited to reducing symptoms and few cures exist. An important driver in this market segment is the increasing aging population, with a consequent growing prevalence of age-related disorders. Also, new [...]
Sutures and staples are at an aging stage in their product life cycle; there are numerous predicate devices, and the materials are well established and cover most of the spectrum of clinical need for suturing. However, a great number of procedure-enhancing devices have been developed in the last seven years, particularly as minimally invasive surgery [...]
One of the more traditional segments in the securement products (sealants, glues, hemostats, sutures, staples, and anti-adhesion) market is hemostats.
Hemostat products can be classified in six subsegments depending on their active principle: thrombin, gelatin, collagen, fibrin, synthetic materials, and other miscellaneous products that exhibit additional attributes.
In the MedMarket Diligence report #S175 addressing these products, the clinical and [...]
The market for surgical closure and securement (sealants, glues, sutures, staples, tapes, hemostasis, anti-adhesion) has entered a phase in which major driving forces are the introduction of new procedures and techniques by the surgical profession, the development by the medical device industry of new wound closure devices and biomaterials, and the growing willingness of surgical [...]
The MedMarket Diligence Report #S175, "Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Market, 2009-2013," details the complete range of sealants & glues technologies used in traumatic, surgical and other wound closure, from tapes, sutures and staples to hemostats, fibrin sealants/glues and medical adhesives. The report details current clinical and technology developments in this huge and rapidly growing [...]
A truly striking amount of industry activity spanning company formation, industry consolidation, product developments and market introductions have taken place over the past two years in the markets for sealants, glues, hemostasis, wound closure and anti-adhesion.
With a relatively low barrier to entry for products with well established routes to FDA and CE Mark approval, application [...]
[Below is an excerpt from Report #S145, "Worldwide Surgical Sealants, Glues & Wound Closure", published Feb. 2007. This report is the subject of a new analysis, Report #S175, to be published December 2008.]
Introduction
The market for surgical closure and securement has entered a phase in which major driving forces are the introduction of new procedures and [...]
Contact:
